The analysis of immune checkpoint molecules from stromal cancers found PD1, lymphocyte activation gene 3 (LAG3), and T-cell immunoglobulin mucin 3 (TIM3) upregulation on tumor-infiltrating T-cells compared matched control blood cells (52). This evidence concerns the gene HAVCR2 and neoplasm.